The Biomarker

The Biomarker: Melanoma

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.

Sanjiv S. Agarwala, MD
Video Categories: The Biomarker

Sign me up!
Friends link: prep4certs
070-411 Braindumps
VCP-550 Braindumps
70-483 Braindumps
HP2-K38
642-997
PK0-003
BH0-013
640-875
C4040-129
JN0-332
E20-547
70-462 Braindumps
400-101 Braindumps
070-461 Braindumps